Published • loading... • Updated
Pulse Biosciences CEO Bought 15,000 Company Shares. Here's What That Means for Investors.
Summary by The Motley Fool
1 Articles
1 Articles
Pulse Biosciences CEO Bought 15,000 Company Shares. Here's What That Means for Investors.
Key PointsCEO Paul LaViolette acquired 15,000 shares for a total cost of ~$295,000 on May 11, 2026.This transaction increased direct holdings by ~1,773.05%, raising the total to 15,846 shares post-trade.The purchase was effected entirely via direct ownership; no indirect holdings or derivative securities were involved.This buy represents a significant increment in capacity, marking a net-buy shift after a period with no open-market purchases by …
·Alexandria, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left1Leaning Right0Center0Last UpdatedBias Distribution100% Left
Bias Distribution
- 100% of the sources lean Left
100% Left
L 100%
Factuality
To view factuality data please Upgrade to Premium
